HTG MOLECULAR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch HTG MOLECULAR and buy or sell other stocks, ETFs, and their options commission-free!

About HTGMQ

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. 

CEO
John L. Lubniewski
CEOJohn L. Lubniewski
Employees
53
Employees53
Headquarters
Tucson, Arizona
HeadquartersTucson, Arizona
Founded
1997
Founded1997
Employees
53
Employees53

HTGMQ Key Statistics

Market cap
221.42
Market cap221.42
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
193.20
Average volume193.20
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current HTG MOLECULAR(HTGMQ) stock price is $0.00, with a market capitalization of 221.42.

On 2026-06-10, HTG MOLECULAR(HTGMQ) stock opened at —, reached a high of —, and a low of —.

HTG MOLECULAR(HTGMQ) shares are trading with a volume of 0, against a daily average of 193.2.

In the last year, HTG MOLECULAR(HTGMQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

In the last year, HTG MOLECULAR(HTGMQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

People also own

Based on the portfolios of people who own HTGMQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.